August 27, 2025

Regeneron tees up myasthenia gravis drug approval after Phase III victory – Clinical Trials Arena

August 26, 2025

Late-stage trial boost for Argenx’s myasthenia gravis drug Vyvgart – European Pharmaceutical Review

August 26, 2025

Regeneron reports key phase 3 win in myasthenia gravis, gears up for FDA filing – Fierce Biotech

August 22, 2025

Factors Influencing Quality of Life in Myasthenia Gravis Patients: Results From a Cross-Sectional Study in South of Iran – Wiley Online Library

August 21, 2025

Serum interleukin-40 increases in anti-AchR antibody-positive myasthenia gravis and correlates with disease activity – Frontiers